1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis 2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL) 3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis 4) Characterization of the molecular mechanism of MLL-induced acute leukemia

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811